Breast Cancer Tumor Care Observational Programme
Breast Cancer Tumor Care Observational Programme
The purpose of this study is to investigate efficacy and tolerability under anastrozole
 (Arimidex) treatment.
Inclusion Criteria:

 -  Postmenopausal women

 -  Already on upfront Arimidex Therapy (Start 1-4 weeks before)

 -  HR+

 Exclusion Criteria:

 -  Premenopausal women

 -  Tamoxifen switch patients